Inherent Biosciences

Salt Lake City, UT · Founded 2019 · Privately Held (backing)

Developer of an epigenetic medicine platform designed to tackle health issues by overhauling the trial-and-error methodology. Inherent Biosciences is based in Salt Lake City, UT and was founded in 2019. It was valued at $18.1 million at its early-stage round in Sep 2022, the last priced event on record. It has raised $9.8 million across 1 recorded round; the latest was a $1.5 million seed round in Aug 2022.

PMV mark · valuation
$18.1M
Oct 2026
Priced at
its early-stage round
Sep 2022
Total raised
$9.8M
Last round
Seed Round
Aug 2022

Who backs Inherent Biosciences?

18 investors
InvestorType
US National Science FoundationOther
Endless Frontier Labs—
Kickstart (US)Venture capital
Cadron Capital PartnersVenture capital
Samothrace Partners—
The Morningstar Philanthropic FoundationOther
Alliance of Angels—
Eunice Kennedy Shriver National Institute of Child Health and Human Development—
Fuel Accelerator—
HealthTech Investors—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Inherent Biosciences investors

18 investors are on record for Inherent Biosciences, including US National Science Foundation, Endless Frontier Labs, Kickstart (US) and Cadron Capital Partners. The seed round in Aug 2022 drew 12 investors.

Free account
More of Inherent Biosciences with a free account
  • ·The complete investor list: 18 names
  • ·Watch Inherent Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like Inherent Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View